XWELL, Inc. Form 8-K Summary
Business Context and Reporting Period
Date of Report: July 6, 2026
Company: XWELL, Inc. (Nasdaq: XWEL)
Event: Entry into a Material Definitive Agreement (Securities Purchase Agreement).
XWELL, Inc. has entered into an agreement to sell its equity interests in two subsidiaries: XpresSpa Holdings, LLC (operating airport retail spa locations) and XpresTest, Inc. (conducting bio-surveillance and multi-pathogen testing at airports). XWELL will retain its health and wellness retail locations outside of airports (the "Retained Ex-Airport Business").
Key Financial Metrics and Transaction Terms
- Base Purchase Price: $13,000,000, subject to customary adjustments for net working capital, closing indebtedness, sale expenses, and closing cash.
- Escrow Amount: $2,650,000 of the purchase price will be held in escrow to secure post-closing obligations and indemnities.
- Indemnification Cap: General claims for breaches of representations and warranties are capped at $2,000,000.
- Financing Status: As of the filing date, the Buyer has not obtained a debt or equity commitment letter but has represented it will have sufficient funds at closing. The Buyer's obligation to close is unconditional and not contingent on financing.
- Termination Fees:
- Buyer Termination Fee: Greater of $1,300,000 or $650,000 plus documented out-of-pocket expenses (capped at $2,000,000).
- Seller Termination Fee: Greater of $1,300,000 or $650,000 plus documented out-of-pocket expenses (capped at $2,000,000).
Note: This filing does not provide specific revenue, profit, cash flow, margin, or debt figures for XWELL or the Target Companies.
Material Changes and Transaction Structure
The transaction represents a significant divestiture of XWELL's airport-based operations. Key structural elements include:
- Asset Scope: Sale includes XpresSpa Airport Business and XpresTest Business. Excludes non-airport retail locations.
- Equity Awards: Outstanding restricted stock awards (RSAs) granted by XpresTest will become fully vested and be cancelled or repurchased for cash at closing based on a mutually agreed valuation.
- Guaranty: FaceHaus LLC (parent of the Buyer) has provided a limited guaranty for the Buyer's obligations, including the Seller Termination Fee, capped at the Purchase Price.
- Support Agreements: Board members, executive officers, and American Ventures LLC Series XXIV XWELL have agreed to vote in favor of the transaction and against alternative proposals.
Guidance, Outlook, Risks, and Conditions
Conditions to Closing:
- Stockholder approval (affirmative vote of a majority of outstanding shares).
- Accuracy of representations and warranties.
- No material adverse effect on the Target Companies.
- Obtaining necessary third-party consents and governmental approvals.
- Satisfaction of minimum cash requirements.
Timeline:
- Termination Date: 180 days from the agreement date, subject to two automatic 30-day extensions if the sole unsatisfied condition is Stockholder Approval.
- Proxy Statement: XWELL must file a preliminary proxy statement within 20 days of the agreement.
Risks and Contingencies:
- Failure to obtain Stockholder Approval or required regulatory approvals.
- Buyer's failure to secure financing (though obligations are unconditional).
- Material adverse effects on the Target Companies prior to closing.
- Diversion of management attention and potential loss of key employees.
- Uncertainty regarding the ability to operate the Retained Ex-Airport Business post-closing.
Investor Verification Checklist
- Verify the final Purchase Price after working capital and debt adjustments.
- Confirm the status of the Buyer's financing commitments prior to the closing date.
- Review the upcoming Proxy Statement for detailed financial data on the Target Companies and the Retained Ex-Airport Business.
- Monitor the outcome of the Stockholder vote required to approve the Sale.
- Assess the impact of the divestiture on XWELL's remaining revenue streams and liquidity position.